Plus Products Advances Strategic Plan with Rebranding, CBD Line Supported by John Legend and Casper Sleep
September 30th, 2019
App, Exclusive, Top News
Some cannabis companies choose to employ a shotgun approach to building their brands, launching a wide variety of products in the hopes that some are successful. The team at Plus Products (CSE: PLUS, OTCQB: PLPRF) has taken a more focused approach, guided by an understanding that the most successful companies began by perfecting one thing and creating an iconic product. The company chose to focus on California, the world’s largest single adult use market, with the goal of “Doing Edibles Better” and establishing the state’s premier edibles brand.
Plus started by building an R&D team led by a Michelin Star Sous Chef, as well as a 12,000 sq.ft. food manufacturing facility, to create a gummies offering that at 5mg of THC per piece was approachable to all levels of cannabis consumers.
That laser focus and commitment to quality has certainly paid off, as Plus is now the state’s top-ranked gummies brand, boasting both the top-selling cannabis products and the best-selling CBD-inclusive product in California according to BDS Analytics. Its Uplift Sour Watermelon Sativa and Restore Blackberry & Lemon Indica Gummies remained the #1 and #2 best-selling products, while its pineapple & coconut flavored CBD Relief was the #5 best-selling SKU and the top CBD-only product in the state.
Having established itself as the premier edibles brand in California, Plus is wasting no time in building on that success and is busy bringing its winning formula to new products, markets, and consumers.
Rebranding Provides Clarity
In July, Plus embarked on an ambitious rebranding process, designed to simplify the decision-making process for consumers, using a mood-based system with three easy to understand banners – Uplift, Balance, and Unwind.
The process was guided by market structure research from Henry J. Rak Associates and designed by the Partners & Spade Agency, which has worked alongside distinctive brands such as Peloton and online eyewear retailer Warby Parker.
The company’s new packaging and product system uses a distinct pastel colour on a white background, and goes beyond the traditional use of Sativa, Hybrid and Indica, to focus on the science behind unique combinations of THC and CBD designed to create the right mix of cannabinoids paired with a targeted flavor profile to give the consumer a desirable experience.
Plus CEO and co-founder Jake Heimark explained, “Cannabis can be confusing. We hope our new system will help reduce some of that confusion. We worked with experienced market researchers to find out why people use cannabis, then translated those findings into an easy-to-use system of cannabis. We are excited to help our customers Uplift their experiences, bring Balance to their everyday, and Unwind without getting unwound. We believe this system will make PLUS even more accessible to new consumers, and we hope our investments in consistency and quality will keep them coming back.”
CBD Line Launched in Partnership with John Legend, Casper Sleep
On September 24, Plus announced the nationwide launch of its 100% hemp-derived CBD line, supported by a brand partnership with American superstar-philanthropist John Legend, who will advocate on behalf of the new product offering.
The CBD line includes three distinct products, labeled in accordance with the new strategy. Each BALANCE Blueberry gummy is infused with 50mg of CBD, while UPLIFT Grapefruit gummies are infused with 50mg of CBD augmented by vitamin B, and SLEEP Blackberry Tea gummies contain 25mg of CBD as well as melatonin to help consumers power down.
Commenting on the partnership, Legend said, “I have been a believer in the benefits of CBD for some time. I was drawn to the Plus team because they’re an innovative, family-run company, and they use science to deliver a consistent, high-quality product. I appreciate that they’re committed to setting a high standard within an industry that has to date been fairly unregulated.
Heimark added, “We established our reputation in edibles by offering customers a consistent and precisely-dosed gummy using high-quality extracts. Our CBD line will build off that expertise, and the earned trust we’ve established, while offering a new experience for consumers designed to help them find their just right.”
The SLEEP line is also being supported through a partnership award-winning global sleep company Casper Sleep Inc..
Neil Parikh, co-founder and chief strategy officer at Casper said, “We’re always exploring new ways to improve sleep across the entire sleep arc — from sunset to sunrise. Like PLUS, we believe sleep is a key part of the wellness equation. Partnering with their team of experts to introduce CBD sleep gummies brings a new way to relax and rest to those who need it.”
The CBD line allows Plus an immediate nation-wide expansion, as Heimark noted.
“Giving the world a simple way to achieve balance has always been our mission, and the Plus CBD line allows us to expand from California to nearly all fifty states overnight. We are thrilled that John Legend and Casper have partnered with our team to support this exciting new initiative.”
The line is also supported by a new FAQ “Learning” page (https://plusproducts.com/pages/faq) to address the questions and concerns of consumers new to CBD, and all three products are currently available for purchase through the company’s newly launched e-commerce platform at www.plusproducts.com.
THC Line Further Expanding
Earlier in the week, Plus also debuted a new line of its best-selling gummies at the Hall of Flowers cannabis trade show in Santa Rosa, California, rolling out three new flavors under its new branding system.
Balance Cucumber Lime gummies contain 3.5mg THC and 1.5mg CBD each, while Uplift Tangerine gummies are infused with 5mg THC and <0.1mg CBD; and Unwind Concord Grape gummies have 4.5mg THC and 0.5mg CBD per piece.
Heimark concluded, “The demand from many of our retail partners and consumers to launch a second line of our gummies has been significant and we are excited to expand our product portfolio to meet those demands. We have high expectations given the success of our original line of gummies, which include the #1 & #2 best-selling cannabis products in California.”
Plus’ first advertising campaign is currently underway across California, encouraging customers to ‘Find Your Just Right’, and will now include these three new products, which are expected to be available across Plus’ network of over 360 retail and delivery partners.
Further Expansions, New Products Imminent
Plus is currently working on a line of infused chocolates, expected in Q1 2020, and plans to follow up its recent move into Nevada with distribution of its THC and CBD-infused products into the Arizona, Illinois, Massachusetts, Michigan, and New York markets. Plus is also considering an expansion into Canada, which is expected to legalize the sale of derivative products by December, in order to begin the process of taking its brand global.
Keep watching this page for more information, and visit https://www.plusproducts.com/
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://www.cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.